Emmessar Biotech And Nutrition (BOM:524768) 3-Year Book Growth Rate : 9.10% (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Emmessar Biotech And Nutrition 3-Year Book Growth Rate?

Emmessar Biotech And Nutrition's Book Value per Share for the quarter that ended in Sep. 2024 was ₹15.55.

During the past 12 months, Emmessar Biotech And Nutrition's average Book Value per Share Growth Rate was 12.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 9.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 15.90% per year. During the past 10 years, the average Book Value per Share Growth Rate was 22.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Emmessar Biotech And Nutrition was 56.80% per year. The lowest was -22.50% per year. And the median was 9.70% per year.

Competitive Comparison of Emmessar Biotech And Nutrition's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Emmessar Biotech And Nutrition's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emmessar Biotech And Nutrition's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emmessar Biotech And Nutrition's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Emmessar Biotech And Nutrition's 3-Year Book Growth Rate falls into.

Emmessar Biotech And Nutrition 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Emmessar Biotech And Nutrition (BOM:524768) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Emmessar Biotech And Nutrition 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Emmessar Biotech And Nutrition's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmessar Biotech And Nutrition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emmessar Biotech And Nutrition Ltd (BOM:524768) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001

Website

https://www.ebnl.org

Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.

Emmessar Biotech And Nutrition Headlines

No Headlines